about
Polymer nanoparticles for drug and small silencing RNA delivery to treat cancers of different phenotypesNano-Synthetic Devices in Leishmaniasis: A Bioinformatics Approach.Nanoformulation of D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock copolymer for siRNA targeting HIF-1α for nasopharyngeal carcinoma therapyAcoustic Cavitation-Mediated Delivery of Small Interfering Ribonucleic Acids with Phase-Shift Nano-EmulsionsCatalytic in vivo protein knockdown by small-molecule PROTACs.In vivo sustained release of siRNA from solid lipid nanoparticles.A novel polyethyleneimine-coated adeno-associated virus-like particle formulation for efficient siRNA delivery in breast cancer therapy: preparation and in vitro analysis.Nanoparticle based galectin-1 gene silencing, implications in methamphetamine regulation of HIV-1 infection in monocyte derived macrophagesDelivery of intracellular-acting biologics in pro-apoptotic therapies.Elevating microRNA-122 in blood improves outcomes after temporary middle cerebral artery occlusion in rats.Recent advances of siRNA delivery by nanoparticles.Nanoparticles targeting HLA-G for gene therapy in cancer.Self-assembly and applications of nucleic acid solid-state films.Nanocarriers: a tool to overcome biological barriers in siRNA delivery.Nanotherapeutic approaches for the treatment of rheumatoid arthritis.Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review.Pharmacogenomics-based RNA interference nanodelivery: focus on solid malignant tumors.Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.Nonviral gene transfer strategies to promote bone regeneration.Chemical Methods to Knock Down the Amyloid Proteins.Hydrogel doped with nanoparticles for local sustained release of siRNA in breast cancer.Engineered Hydrogels for Local and Sustained Delivery of RNA-Interference Therapies.Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA.Efficient intracellular siRNA delivery by ethyleneimine-modified amphiphilic macromolecules.Intracellular Delivery of siRNA by Polycationic Superparamagnetic Nanoparticles.Nano-based delivery of RNAi in cancer therapy.RNA interference-based therapy and its delivery systems.Grand challenges in modulating the immune response with RNAi nanomedicines.Glycosylated Triterpenoids as Endosomal Escape Enhancers in Targeted Tumor Therapies.Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma.Argonaute2 is a potential target for siRNA-based cancer therapy for HT1080 human fibrosarcoma.Azithromycin cationic non-lecithoid nano/microparticles improve bioavailability and targeting efficiency.RNAi in Respiratory DiseasesControlled Release of DNA From Photoresponsive Hyperbranched Polyglycerols with Oligoamine Shells
P2860
Q26830537-CD52B644-06A9-40A9-B907-5481DC721372Q26852294-43CFCECB-054E-4EE4-BEBE-17B42751077DQ28649552-495CE81D-1331-4A00-8DEB-AF0F5A71389AQ30378008-9AD8D7D9-F1D3-429C-9748-05940E5B98E0Q34480735-5869897A-28AE-4D04-B9D8-2E81A08CDFDEQ35635763-A5F30296-454B-4123-8BD1-4E212AB93D18Q35972537-099D8404-F82C-4077-8C47-89784594D763Q36166289-DD5CE2C1-7BD1-4653-9A27-B1D9FEDD6AB3Q36588920-DA41B944-6F05-4C44-BCB2-21E8FA3390C0Q37158084-B14D7EAC-2DE7-4D5D-8735-019D8F0543CDQ37854061-D02DDB90-B8AB-4E32-92A3-ABFBB09CB2C6Q37866158-A73430A4-5802-4735-B37B-D18EA8B73304Q37884528-5219CF58-8126-4379-AB07-155B5EE049B0Q37891091-20E4BFFA-B7B3-46A4-BB79-E0A17C5CB498Q37916426-896E7187-68B3-456E-BA87-03C3B9EABA49Q37922198-CFAA9330-C91D-4397-B550-1A38C08E243CQ38015528-1F1CFFD3-F78B-4B77-B9E2-2FD7DC3998B6Q38037048-E88DE779-A110-42D0-AE7E-E65D106FE087Q38095891-8A2EE92D-A9EA-4189-B515-EF12FA6603C5Q38740479-0EC83B7D-204B-4AC4-A020-B96F1B58D155Q38967041-6710049B-DCB8-4B1B-9E82-D9D7C90EFFDDQ39038930-32B1587D-1ECB-4093-8DF5-BB76781ABE8FQ39461620-01821754-5F84-4CE1-8F35-B4D8BD4B4FB2Q39500124-B4A46C06-F968-4932-9E04-4FAED399712FQ42324117-F7E329B3-5BE8-429F-9E16-C06ABDA315F4Q42339315-2640E1C9-DB56-40A5-B3AA-1FD06790A884Q47565462-59BE6993-A8D1-4F1C-824D-F8661743BACAQ47578379-25F2E083-E88D-4FF5-B67A-FE2C0F3135CCQ50985144-473E97C1-C10F-4BE3-A3B4-B84A156BC742Q52719561-6402A4C3-0821-471F-A8BC-3DA11D059BFCQ53229270-0196E12B-F43B-43BB-AEE1-BD6187578619Q53450275-BC235CCD-5DE5-46F0-A93F-8B1953201F00Q58061971-D9702C4C-4E6C-4216-A217-E4CC3B99B807Q58324590-0DE1045D-AD68-4CE9-8EDF-0D3CFA3A2606
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
siRNA applications in nanomedicine
@en
siRNA applications in nanomedicine.
@nl
type
label
siRNA applications in nanomedicine
@en
siRNA applications in nanomedicine.
@nl
prefLabel
siRNA applications in nanomedicine
@en
siRNA applications in nanomedicine.
@nl
P2860
P356
P1476
siRNA applications in nanomedicine
@en
P2093
Talar Tokatlian
Tatiana Segura
P2860
P304
P356
10.1002/WNAN.81
P577
2010-05-01T00:00:00Z